Should Systematic Lymphadenectomy Be Performed in Suboptimally Debulked Patients with Stage III Ovarian Carcinoma? A Degog Study


Saygili U., Guclu S., Erten O., POSACI C.

OVARIAN CANCER: NEW RESEARCH, vol.19, pp.157-170, 2009 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 19
  • Publication Date: 2009
  • Journal Name: OVARIAN CANCER: NEW RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.157-170
  • Keywords: lymphadenectomy, ovarian carcinoma, cytoreduction, survival, LONG-TERM SURVIVAL, PARA-AORTIC LYMPHADENECTOMY, LYMPH-NODE INVOLVEMENT, CYTOREDUCTIVE SURGERY, PARAAORTIC LYMPHADENECTOMY, NEOADJUVANT CHEMOTHERAPY, COMBINATION CHEMOTHERAPY, GYNECOLOGIC MALIGNANCIES, PELVIC LYMPHADENECTOMY, INTERVAL DEBULKING
  • Dokuz Eylül University Affiliated: Yes

Abstract

The therapeutic importance of lymphadenectomy in ovarian carcinoma is controversial. The aim of this study is to determine whether systematic lymphadenectomy is necessary in suboptimally debulked patients with stage Ill ovarian carcinoma.